Ledger.Open graph →
SEC Form D · Amendment · filed March 1, 2016

Mersana Therapeutics, Inc

Offering
$35.5M
Sold
$10.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Elaine J. Jones · CAMBRIDGE, MADirectorAnna Protopapas · CAMBRIDGE, MAExec · DirectorDonald Bergstrom · CAMBRIDGE, MAExecThomas J. Beck · CAMBRIDGE, MADirectorWayne J. Foster · CAMBRIDGE, MAExecSara J. Nayeem · CAMBRIDGE, MADirectorMichael J. Kaufman · CAMBRIDGE, MAExecTimothy Lowinger · CAMBRIDGE, MAExecDavid Mott · CAMBRIDGE, MADirectorEva Jack · CAMBRIDGE, MAExecDavid B. Way · Vancouver, British Columbia, CanadaExecBrian H. Madocks · New York, NYDirectorAlvin H. Crawford, Jr · New York, NYExecJackalyne Pfannenstiel · San Francisco, CAExecAndrew Trader · San Francisco, CAExec · DirectorThomas G. Mendell · New York, NYExec · DirectorGerardo Gomez De La Sierra · San Antonio, TXDirectorStacey Boyd · San Francisco, CAExec · DirectorScarlett O'Sullivan · San Francisco, CAExec · DirectorMariano Gomez De La Sierra · San Antonio, TXExec · DirectorDavid Milne · Boston, MAExecPaul Laviolette · Boston, MAExec · DirectorKate Bingham · London, United KingdomExecBrian A. Sullivan · Los Angeles, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗